Evidence map›Paper›PMID 34103587›Full record

ArticleScientific reports2021

Early assessment of lung function in coronavirus patients using invariant markers from chest X-rays images.

Mohamed Elsharkawy, Ahmed Sharafeldeen, Fatma Taher, Ahmed Shalaby, Ahmed Soliman, Ali Mahmoud, Mohammed Ghazal, Ashraf Khalil, Norah Saleh Alghamdi, Ahmed Abdel Khalek Abdel Razek and 5 more

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 1 pooled it
3.5field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 1 synthesis or guideline pooled it, 26 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 6 institutions in 4 countries.

Mohamed Elsharkawy *BioImaging Laboratory, Department of Bioengineering, University of Louisville, Louisville, KY, USA.
Ahmed Sharafeldeen *BioImaging Laboratory, Department of Bioengineering, University of Louisville, Louisville, KY, USA.
Fatma Taher *College of Technological Innovation, Zayed University, Dubai, UAE.
Ahmed ShalabyBioImaging Laboratory, Department of Bioengineering, University of Louisville, Louisville, KY, USA.
Ahmed SolimanBioImaging Laboratory, Department of Bioengineering, University of Louisville, Louisville, KY, USA.
Ali MahmoudBioImaging Laboratory, Department of Bioengineering, University of Louisville, Louisville, KY, USA.
Mohammed GhazalDepartment of Electrical and Computer Engineering, Abu Dhabi University, Abu Dhabi, UAE.
Ashraf KhalilCollege of Technological Innovation, Zayed University, Dubai, UAE.
Norah Saleh AlghamdiCollege of Computer and Information Science, Princess Nourah bint Abdulrahman University, Riyadh, Saudi Arabia.
Ahmed Abdel Khalek Abdel RazekDepartment of Diagnostic Radiology, Faculty of Medicine, Mansoura University, Mansoura, Egypt.
Eman AlnaghyDepartment of Diagnostic Radiology, Faculty of Medicine, Mansoura University, Mansoura, Egypt.
Moumen T El-MelegyFaculty of Engineering, Assiut University, Assiut, Egypt.
Harpal Singh SandhuDepartment of Ophthalmology and Visual Sciences, University of Louisville, Louisville, KY, USA.
Guruprasad A GiridharanBioImaging Laboratory, Department of Bioengineering, University of Louisville, Louisville, KY, USA.
Ayman El-BazBioImaging Laboratory, Department of Bioengineering, University of Louisville, Louisville, KY, USA. aselba01@louisville.edu.
University of Louisville · USMansoura University · EGZayed University · AEAbu Dhabi University · AEAssiut University · EGPrincess Nourah bint Abdulrahman University · SA

Funding

The financial support in part of Science, Technology, and Innovation Funding Authority (STIFA) in Egypt Grant # 43744
6 · The paper itself

Abstract

The primary goal of this manuscript is to develop a computer assisted diagnostic (CAD) system to assess pulmonary function and risk of mortality in patients with coronavirus disease 2019 (COVID-19). The CAD system processes chest X-ray data and provides accurate, objective imaging markers to assist in the determination of patients with a higher risk of death and thus are more likely to require mechanical ventilation and/or more intensive clinical care.To obtain an accurate stochastic model that has the ability to detect the severity of lung infection, we develop a second-order Markov-Gibbs random field (MGRF) invariant under rigid transformation (translation or rotation of the image) as well as scale (i.e., pixel size). The parameters of the MGRF model are learned automatically, given a training set of X-ray images with affected lung regions labeled. An X-ray input to the system undergoes pre-processing to correct for non-uniformity of illumination and to delimit the boundary of the lung, using either a fully-automated segmentation routine or manual delineation provided by the radiologist, prior to the diagnosis. The steps of the proposed methodology are: (i) estimate the Gibbs energy at several different radii to describe the inhomogeneity in lung infection; (ii) compute the cumulative distribution function (CDF) as a new representation to describe the local inhomogeneity in the infected region of lung; and (iii) input the CDFs to a new neural network-based fusion system to determine whether the severity of lung infection is low or high. This approach is tested on 200 clinical X-rays from 200 COVID-19 positive patients, 100 of whom died and 100 who recovered using multiple training/testing processes including leave-one-subject-out (LOSO), tenfold, fourfold, and twofold cross-validation tests. The Gibbs energy for lung pathology was estimated at three concentric rings of increasing radii. The accuracy and Dice similarity coefficient (DSC) of the system steadily improved as the radius increased. The overall CAD system combined the estimated Gibbs energy information from all radii and achieved a sensitivity, specificity, accuracy, and DSC of 100%, 97% ± 3%, 98% ± 2%, and 98% ± 2%, respectively, by twofold cross validation. Alternative classification algorithms, including support vector machine, random forest, naive Bayes classifier, K-nearest neighbors, and decision trees all produced inferior results compared to the proposed neural network used in this CAD system. The experiments demonstrate the feasibility of the proposed system as a novel tool to objectively assess disease severity and predict mortality in COVID-19 patients. The proposed tool can assist physicians to determine which patients might require more intensive clinical care, such a mechanical respiratory support.

Indexed as

Radiography, ThoracicTomography, X-Ray ComputedAdultAgedCOVID-19Deep LearningFemaleHumansImage Processing, Computer-AssistedLungMaleMiddle AgedStochastic Processes

Identifiers

PMID34103587
PMCPMC8187631
OpenAlexW3171964358

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.